A study from Madras Medical College compares two STEMI treatment strategies, highlighting effective outcomes in resource-limited settings.
These findings are published in July 2025 in Cardiovascular Revascularization Medicine.
A recent study published in the Journal of the American Medical Association revealed that the use of sodium-glucose ...
Cardiovascular disease remains the leading cause of mortality worldwide, necessitating deeper insights into its molecular underpinnings beyond genetic predisposition. Epigenetic modifications, ...
Stories this month focused on TAVI in low-risk patients, statin safety, the burden of CKM syndrome in the US, and more.
TradeWinds depends on being able to display ads on our services in order to finance our journalism.
Peer-reviewed paper indicates icosapent ethyl (IPE) was associated with fewer total hospitalizations and fewer days lost due to hospitalization ...
2don MSN
A safer, more effective atrial fibrillation treatment method using magnetic gel may be on the way
Atrial fibrillation is a common heart condition characterized by a rapid, irregular heartbeat stemming from the heart's upper ...
Manage your stage 3 ET diagnosis with this guide on high-risk treatments, side effects and new NCCN-preferred options to empower your next visit. While essential thrombocythemia (ET) is classified as ...
Older adults with subclinical hypothyroidism who were prescribed levothyroxine had lower risk for cardiovascular events than those not prescribed the therapy, according to findings published in ...
A Phase I/IIa clinical trials co-led by Linda Laux, MD, from Ann & Robert H. Lurie Children's Hospital of Chicago, show that ...
Atherosclerotic cardiovascular disease (ASCVD) is a leading cause of morbidity and mortality globally. Low-density lipoprotein cholesterol is a causal risk factor for atherosclerotic cardiovascular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results